Price T Rowe Associates Inc Molecular Templates, Inc. Transaction History

Price T Rowe Associates Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.68 - $11.25 $12,628 - $208,923	-18,571 Reduced 65.0%	10,000 $8,000
Q2 2022 Aug 15, 2022	SELL	$0.81 - $3.43 $2,911 - $12,327	-3,594 Reduced 11.17%	28,571 $26,000
Q1 2022 May 16, 2022	BUY	$2.27 - $4.13 $2,724 - $4,956	1,200 Added 3.88%	32,165 $111,000
Q4 2021 Feb 14, 2022	SELL	$3.37 - $6.87 $4.08 Million - $8.31 Million	-1,209,982 Reduced 97.5%	30,965 $121,000
Q3 2021 Nov 15, 2021	SELL	$5.78 - $7.86 $16,264 - $22,118	-2,814 Reduced 0.23%	1,240,947 $8.33 Million
Q2 2021 Aug 16, 2021	BUY	$7.82 - $12.44 $3.11 Million - $4.95 Million	397,740 Added 47.01%	1,243,761 $9.73 Million
Q1 2021 May 17, 2021	BUY	$9.33 - $14.05 $7.61 Million - $11.5 Million	815,631 Added 2683.88%	846,021 $10.7 Million
Q4 2020 Feb 16, 2021	BUY	$8.48 - $12.23 $257,707 - $371,669	30,390 New	30,390 $285,000

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $7.33M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.